Novartis unit Sandoz set to start trading after completing spinoff

Novartis has completed the planned spin-off of its generics and biosimilars business, Sandoz, which will begin trading on the SIX Swiss Exchange on Wednesday.

from Health and Science https://ift.tt/XJNOkjy
https://ift.tt/RbYwjrJ
https://ift.tt/KHa3k9V